OpenAI is now letting users work with third-party apps and complete certain tasks without leaving ChatGPT’s interface.

Dearborn — Robert Gardiner, an engineering manager in sales and marketing for Ford Motor Co., leaves his home in Ann Arbor to make his more than 30-minute commute to be at the automaker's Wagner Place ...

Nvidia announced Monday it plans to invest up to $100 billion in OpenAI as part of a deal to build out massive data centers for training and running AI models. The companies say they signed a letter ...

The Day of the Jackal came out of nowhere last year as one of the most surprising success stories of 2024. The spy thriller series, starring Eddie Redmayne and Lashana Lynch, has been renewed for ...

Singapore-based Flex has a diverse workforce across 30 countries. It offers advanced manufacturing solutions and additional value to customers through a wide array of services, including design and ...

The Park City location of the U.S. Postal Service was set to close at the end of September, however, a new contract will keep the location up and running. MrIncredible Getty Images/iStockphoto A Park ...

DEAR ABBY: I lost my husband two months ago after a long, debilitating illness. I loved him very much, and the loss was very difficult, although not unexpected. After his funeral, an old friend called ...

DEAR ABBY: I lost my husband two months ago after a long, debilitating illness. I loved him very much, and the loss was very difficult, although not unexpected. After his funeral, an old friend called ...

Morgan Barnaby / OPB Salem city leaders will receive an update this week on drawdowns to the Detroit Reservoir and how it will affect drinking water for around 200,000 residents. At a City Council ...

Nvidia to supply OpenAI with data center chips Deal involves non-voting shares and chip purchases Potential antitrust scrutiny due to Nvidia's investment The move underscores the increasingly ...

Leucovorin brings hope as the first potential autism treatment, but with RFK Jr. weighing whether to fast-track approval, scientists worry about trust. When Nathaniel Schumann entered the clinical ...